The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world (Harm Reduction International)
Archives for October 2020
Bibliography: All Publications
How to use the ASSIST-Lite screening tool to identify alcohol and drug use and tobacco smoking
Health and social care professionals are well placed to provide interventions targeted at all substances. This tool will help you to identify risky drug and alcohol use and tobacco smoking, and respond in an evidence-based way. This will contribute to reducing premature mortality and morbidity (PHE)
Synthetic cannabinoid receptor agonists
This report provides an updated harms assessment to the ACMD’s previous reports on synthetic cannabinoid receptor agonists
Police powers and procedures, England and Wales, year ending 31 March 2020
Statistics on stop and search, arrests for notifiable offences, detentions under the Mental Health Act 1983, fixed penalty notices for motoring offences, breath tests, and other PACE powers (Home Office)
Drug crime: Statistics for England and Wales
This briefing paper looks at drug crime prevalence in England and Wales and the criminal justice outcomes for those found guilty of drug offences. It also covers the impacts of drug misuse (UK Parliament)
Drug-related hospital statistics
A National Statistics publication for Scotland
Characteristics of people who used the Melbourne and Sydney medically supervised injecting facilities surveyed in the Illicit Drug Reporting System 2019
In this bulletin, we summarise findings from the Sydney and Melbourne survey samples who report use of the supervised injecting facilities in their city (NDARC)
Expanded Access to Naloxone Can Curb Opioid Overdose Deaths
Changes to prescribing laws to improve availability of the overdose reversal drug can reduce fatalities (PEW)
Response to the ACMD report on the misuse of fentanyl and fentanyl analogues
The following is a partial response to your recommendations as further work is required to implement some of these. I have indicated below where this applies (Home Office)
How and why vendors sell on cryptomarkets
Cryptomarkets represent a growing component of the global illicit drugs trade. Australia is over-represented in the proportion of online vendors who use these platforms to reach drug consumers (Australian Institute of Criminology)
Chief constable’s annual report 2019—2020
The report contains an overview of the work that the Constabulary undertook during the year that ended on 31st March 2020; it also contains simple data charts, an interpretation of that data, an assessment of some important emerging issues and it casts an eye to the immediate future (Isle of Man)
Deaths related to drug poisoning in England and Wales: 2019 registrations
Deaths related to drug poisoning in England and Wales from 1993 to 2019, by cause of death, sex, age and substances involved in the death (Office for National Statistics)
Trends in the availability and type of drugs sold on the internet via cryptomarkets, May 2019 – May 2020
This bulletin series reports on trends in the availability and type of substances sold on the internet via cryptomarkets over the last 13 months (a new bulletin is released typically every four months). The current bulletin focuses on analysis of listings from 1 May 2019 to 31 May 2020 (NDARC)
The impact of arrest and seizure on drug crime and harms: A systematic review
Drawing on the Global Policing Database (GPD), this review assesses the impact of supplier arrests and seizures on drug crime, drug use, drug price, drug purity, and drug harm outcomes (Australian Crime Commission)
Increase in Drug Overdose Deaths Involving Cocaine: United States, 2009–2018
This Data Brief provides additional information on drug overdose deaths involving cocaine by examining trends in rates by sex, age group, race and Hispanic origin, and by concurrent involvement of opioids from 2009 through 2018 (CDC)
Drug-related homicide in Europe: data protocol
This report is part of the EMCDDA activity around the development and improvement of drug supply indicators, which are designed to reflect developments in drug markets as well as the markets’ wider harms and impact